Immunity against Influenza virus disease and safety of FluQuadri (marketed vaccine with protection against 4 types of influenza virus) in participants 60 years of age and older
Phase 4
Completed
- Registration Number
- CTRI/2020/09/027913
- Lead Sponsor
- Seth GSMC and KEM Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Male or female of no child bearing potential 60 years and above at the time of study vaccine administration.
2. Provide written informed consent.
3. The participant is willing to comply with study protocol requirements, including availability for all scheduled visits of the study.
4. Healthy, as determined by medical history and clinical assessment of the investigator.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Haemagglutinin Antibody Inhibition (HAI) antibody titresTimepoint: Day 28
- Secondary Outcome Measures
Name Time Method